CN107712875A - 黑藜麦减肥代餐 - Google Patents
黑藜麦减肥代餐 Download PDFInfo
- Publication number
- CN107712875A CN107712875A CN201711029459.4A CN201711029459A CN107712875A CN 107712875 A CN107712875 A CN 107712875A CN 201711029459 A CN201711029459 A CN 201711029459A CN 107712875 A CN107712875 A CN 107712875A
- Authority
- CN
- China
- Prior art keywords
- black
- quinoa
- black quinoa
- kilograms
- inulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000006162 Chenopodium quinoa Species 0.000 title claims abstract description 60
- 239000000284 extract Substances 0.000 claims abstract description 22
- 229920001202 Inulin Polymers 0.000 claims abstract description 18
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 18
- 229940029339 inulin Drugs 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 241000206572 Rhodophyta Species 0.000 claims abstract description 15
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 10
- 239000002002 slurry Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 11
- 235000013339 cereals Nutrition 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 150000002148 esters Chemical class 0.000 abstract description 4
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 4
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 230000001151 other effect Effects 0.000 abstract description 3
- 230000001093 anti-cancer Effects 0.000 abstract description 2
- 230000035568 catharsis Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 208000008589 Obesity Diseases 0.000 description 9
- 235000020824 obesity Nutrition 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 206010033307 Overweight Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 210000001789 adipocyte Anatomy 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000036186 satiety Effects 0.000 description 4
- 235000019627 satiety Nutrition 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 240000006122 Chenopodium album Species 0.000 description 3
- 235000009344 Chenopodium album Nutrition 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 229930014669 anthocyanidin Natural products 0.000 description 3
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 3
- 235000008758 anthocyanidins Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000009200 high fat diet Nutrition 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000021407 appetite control Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000015493 Chenopodium quinoa Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000567232 Ochnaceae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000786103 Steatomys pratensis Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021170 buffet Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 208000030941 fetal growth restriction Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
黑藜麦减肥代餐属于功能食品，尤以青藏高原天然无污染有机谷物黑藜麦提取物、胡椒碱、红藻萃取物、菊粉丙酸酯等原料制成的功能食品。该产品具有提高免疫力、减肥瘦身、降血压、降血脂、降血糖、通便排毒、抗癌等功效。
Description
一、技术领域：本发明属功能固体食品，尤以青藏高原天然无污染有机谷物黑藜麦提取物等原料，采取现代先进工艺加工而成的功能食品。
二、背景技术：本发明以黑藜麦提取物、胡椒碱、红藻萃取物、菊粉丙酸酯等原料制成的功能固体饮品。该产品具有提高免疫力、减肥瘦身、降血压、降血脂、降血糖、通便排毒、抗癌等功效。目前市场上还没有同类产品，创新研发该产品可为给减肥瘦身的人群提供了一种新产品。该产品以纯天然有机谷物和生物活性成分为原料制成的减肥代餐、纯度高、吸收好、生物活性强、无任何副作用、口感纯正、服用方便、效果明显，适应于各年龄段的减肥人群服用。
三、发明内容：肥胖是一种营养代谢综合失调性疾病和低度全身慢性炎症。研究发现，肥胖病因相当复杂，不仅有明显的遗传性，还与饮食和运动密切相关。在今天肥胖已成为一个社会严重的公共卫生问题。世界卫生组织(WHO)认为，肥胖与艾滋病、吸毒、凶酒并列为世界四大社会问题，医学界称之为人类死亡率高的癌症，冠心病、糖尿病、高血压、高血脂、心脑血管疾病都与肥胖直接有关。随着我国经济的快速发展，人民生活水平的不断提高，肥胖正在成为一个关注的流行病。根据世界卫生组织的统计数学显示，全球超重人数超过10亿多，有3亿多人严重肥胖，而发展中国家的肥胖比例大幅增加。在我国根据卫生部、科技部和国家统计局公布的营养与健康状况调查结果显示，我国13亿人口中有2亿人超重，特别是儿童超重迅速增长。预计今后肥胖患病率还将会有较大幅度的增长，肥胖会给国民健康造成严重的威胁，也会给个人和社会带来沉重的经济负担。
四、原料配方：黑藜麦提取物50-100千克、胡椒碱2-6千克、红藻萃取物6-12千克、菊粉丙酸酯10-20千克为原料。
五、技术方案：
(一)黑藜麦提取物(Chenopodium quinoa willd)，又叫南美藜，奎麦，金谷子等。原产于美洲安第斯山区，是印加土著居民的主要传统食物，由于具有独特丰富全面的营养价值，养育了印加民族，被称为粮食之母，也可代替婴幼儿奶粉食用。近几年来引进我国青海等地区试种成功，在青藏高原海拔2800米的柴达木盆地大面积种植。黑藜麦属藜木科双叶子黑藜麦的成熟种子。性平味甘，具有全面均衡补充营养，有增强机体功能和增强免疫功能，修复体质，提高机体适应能力、调节内分泌、促进儿童生长发育、预防疾病、美容养颜、减肥、通便、延缓衰老、防癌抗癌、降血压、降血脂、降血糖、防治心脑血管疾病、辅助治疗慢性疾病等功效，也是孕产妇的超级营养食品，被联合国粮农组织认为黑藜麦是唯一单体植物既满足人体基本营养需求的食物，推荐黑藜麦为最适宜人类完美的营养食品，并列为全球10大健康营养的“超级谷物”，“未来食品”，以促进人类的健康。尤其适应于高血压、高血脂、高血糖、心脑血管疾病，以及婴幼儿、孕产妇、儿童、老年人等特殊体质等人群，长期食用效果显著。
营养成分：黑藜麦含有丰富的蛋白质(高达26％，且品质与奶粉和牛肉类相当)，碳水化合物、脂肪、多种氨基酸、其中含有人体必需的全部9种氨基酸，比例适当且易吸收，还富含不饱和脂肪酸、花青素、类黄酮、β-葡聚糖、胆碱、甜菜碱、α一亚麻酸、矿物质钙、镁、磷、钾、铁、锌、硒、锰、铜等，维生素B族、叶酸、维生素E等化合物，膳食纤维含量高达7.1％，不含胆固醇。
生理功能：1、增强免疫功能：研究发现，黑藜麦具有增强机体防病抗病能力，调节机体免疫功能的作用，其中黑藜麦中丰富的蛋白质是构成血红球和抗体的主要成分。实验证明，严重缺乏会使人的免疫细胞中的淋巴球大减，造成严重的免疫机能下降，且易感染疾病。另外，黑藜麦中含有β-葡萄糖对机体免疫系统有极强的作用，具有活化细胞的功能，防止机体被感染和修复被破坏的组织，同时，黑藜麦中β-葡萄糖还有激活细胞，提高免疫功能的作用。而黑藜麦中均衡的营养物质也可通过改善体质提高免疫力。
2、降血压：数据研究表明，黑藜麦与控制血压有一定作用。研究推测，这可能是由黑藜麦中的钾、镁和钙平衡有利于降血压。此外黑藜麦中另一个降压因素可能是降压生物活性肽，黑藜麦中的蛋白质是血管紧张转换酶(ACE)抑制肽的来源，可以通过酶水解，胃肠道消化或食品加工过程释放出来。目前从多种蛋白质如酪蛋白、乳清蛋白、β-球蛋白等均能分离出抗高血压活性肽，在以自发性高血压大鼠实验中具有降血压活性。
3、降血脂：黑藜麦晶及其口服冲剂、黑藜麦粉对高脂血症和高脂血症家兔血清总胆固醇(TC)、甘油三酯(TG)、β-脂蛋白等均有明显的抑制作用，并能明显升高高密度脂蛋白的胆固醇(HDL-C)水平，其降血脂成分为食物纤维不溶蛋白及脂类等。
4、抗动脉粥样硬化：黑藜麦粉能明显抑制家兔血脂升高及红细胞胆固醇上升；能明显减轻动脉壁和肝脏脂质沉积，对主动脉内膜不斑块病变的形成有良好的抑制作用。
5、降血糖：研究认为，每天摄入适量的黑藜麦粉可降低患糖尿病的几率。因为黑藜麦中含有的钙、镁、维生素和β-葡萄糖可以增强人体合理使用胰岛素的功能。据报道，最新研究发现，经常进食黑藜麦粉食品，其中含有的脂肪酸可降低患糖尿病的风险，动物实验发现，动物体内存在的脂肪酸可帮助降低胰岛素抵抗性，他们对人体通过对黑藜麦制品摄入脂肪酸进行调查，研究了3700多名65岁以上老人跟踪调查，结果显示，与进食黑藜麦制最少的人相比，进食黑藜麦制品多的人患糖尿病的几率要低63％，同样也可以起到降低胰岛素抵抗作用，从而有效预防糖尿病。
6、减肥：多项研究表明，在摄入热量不变的前提下，饮食中增加黑藜麦制品的摄入量有助减肥。因为黑藜麦制品中含有丰富的胆碱和其他一些特殊的活性成分，能帮人体燃烧脂肪，减少脂肪堆积和控制体着有着重要的作用。黑藜麦制品有助于控制体重的另一因素可能与它含有丰富的蛋白质和膳食纤维能增加人的饱腹感对食欲控制有关，因为蛋白质和膳食纤维能产生较强的饱腹感，延缓胃排空，从而减少其他食物的摄入量来控制食欲，达到减肥的作用。另外，黑藜麦含有丰富的花青素，可以抑制脂肪细胞、巨噬细胞和血管内皮细胞，因而发挥降血脂、抗肥胖、抗炎和抗糖尿病的独特功效来实现减肥的显著作用。
7、抗肥胖炎症：肥胖是代谢炎症的诱发因素，因此，黑藜麦含有丰富的花青素，对肥胖的抑制作用可以从源头抑制代谢炎症反应，通过对小鼠12周的实验显示，可显著减轻体质量，减少白色脂肪组织量，显著抑制炎性细胞因子的释放和减少脂肪组织产生的炎症介质。
8、通便：黑藜麦中含有丰富的膳食纤维，能使食物在肠内通过的时间缩短，使大肠内的粪便量相对增加，有助于大肠的蠕动，使粪便易予排出，从而达到通便作用。
此外，黑藜麦还具有延缓衰老、防治心脑血管疾病、护眼明目、通便、辅助治疗慢性疾病等作用。
(二)胡椒碱减肥：最新研究表明，胡椒碱可抑制新的脂肪细胞形成；对肥胖患者具有显著的减肥功效。据报道，国外研究发现，胡椒碱可以调节基因活跃程度，从而控制新的脂肪细胞的形成过程。通过这种途径，胡椒碱还可以诱发一种新陈代谢的链式反应，降低血液组织中的脂肪含量，从而起到显著减肥的作用。这项新研究为研发治疗肥胖症药物或减肥产品提供新方法。
(三)红藻萃取物：(Gelidium amansi extract GAE)红藻萃取物可抑制高脂肪饮食诱导的肥胖。研究证实，持续12周摄入含红藻萃取物的高脂肪饮食对老鼠的体重具有显著的抑制作用，对肥胖老鼠有明显的减肥效果。另据报道，国外研究人员分析红藻萃取物对肥胖大鼠的体重、脂肪含量、血浆、肝脏脂质、脂肪因子分泌物和脂质代谢因子表达的影响，通过8周对肥胖大鼠对比实验结果显示，大鼠减少的体重和共轭亚油酸(CLA)组大鼠一样，共轭亚油酸是一种具有显著减肥功效的脂肪酸。研究还显示，与高脂肪组大鼠相比红藻萃取物组大鼠的体重明显降低。此外，红藻萃取物还可明显减少大鼠体重、脂肪组织质量、瘦蛋白浓度，血清和肝脏中甘油三酯和低密度酯蛋白水平。红藻萃取物还可刺激酯质代谢因子表达，降低高脂饮食诱导肥胖大鼠的体重。
(四)菊粉丙酸酯减肥瘦身：最新研究发现，菊粉丙酸酯可以抑制人的食欲，防止进食过量，具有很好的减肥作用。实验证实，肥胖者食用菊粉丙酸酯后，吃自助餐时可以减少16％的食量，能防止过量饮食。将菊粉丙酸酯添加在饼干中会使人长时间产生饱腹感，因为菊粉丙酸酯可刺激肠道产生可作用于大脑的激素，从而使饱腹感来得快，且持续时间长。通过对肥胖者进行随机双盲对比实验，研究人员对60名肥胖志愿者随机分为两组，其中一组服用菊粉丙酸酯，另一组服用魔芋粉作为对照组，实验结果显示，菊粉丙酸酯能有效防止饮食过量，另外，服用菊粉丙酸酯后，胃和肝脏上的脂肪也减少。因此，菊粉丙酸酯具有显著的抑食减肥作用。另外菊粉丙酸酯还具有通便的作用，也有利于减肥。
综上所述：本产品通过对36名女性每天服用黑藜麦减肥代餐，通过6周后的检测其体内脂肪含量，结果显示，每个试验者的基础代谢率平均提高13.8％，体重平均减少3.7％，体内平均脂肪下降3.3％，腰围平均减少3.6厘米。通过上数据表明，黑藜麦减肥代餐具有显著的减肥功效。
六、制作工艺：
1、原料处理：先将黑藜麦捡杂，清洗、沥干。
2、浸泡：将清洗后的黑藜麦加入1∶1-5水浸泡8-12小时。
3、磨浆：将浸泡后的黑藜麦加入1∶8-10的水磨成浆液。
4、过滤：将磨好的黑藜麦浆液送入过滤机，进行过滤。
5、均质浓缩：将过滤后的黑藜麦浆液加热至60℃，在25MPa下进行均质后浓缩至含固体物40-50％。
6、干燥：将浓缩后的黑藜麦浆液送入低温真空干燥机，真空度控制在0.696千帕，温度控制在30-40度，进行真空干燥，干燥时间2-4小时。
7、粉碎过筛：将干燥后黑藜麦固体物进行粉碎过80-10目筛(即黑藜麦速溶粉)。
8、混合搅拌：将黑藜麦粉与原料配方中剩余的原料胡椒碱、红藻、菊粉丙酸酯混合，充分搅拌均匀。
9、检验包装：将混合后的原料，经检验合格，包装为成品。
七、质量标准：
1、理化指标：
2、服用方法：每日30-100克。
3、适用人群：男女老幼、儿童、青少年等各年龄段肥胖人群服用。
八、具体实施方式：
实施例：取黑藜麦提取物50-100千克、胡椒碱2-6千克、红藻萃取物6-12千克、菊粉丙酸酯10-20千克为原料，经过将以上原料捡杂、清洗、沥干，加入1∶1-5的水浸泡8-12小时后，再加入8-10倍的水磨成浆液，送入过滤机，过滤后将黑藜麦浆液加热至60℃，在25MPa下进行均质后浓缩至含固体物40-50％，将浓缩后的黑藜麦浆液送入低温真空干燥机，真空度控制在0.696千帕，温度控制在30-40度，进行真空干燥，干燥时间2-4小时。干燥后的黑藜麦固体物进行粉碎后过80-100目筛(即黑藜麦速溶粉)，再与原料配方中剩余的原料胡椒碱、红藻萃取物、菊粉丙酸酯混合，充分搅拌均匀，经检验合格，包装为成品。
Claims (1)
1.黑藜麦减肥代餐的制作工艺，其组成特征为：取黑藜麦提取物50-100千克、胡椒碱2-6千克、红藻萃取物6-12千克、菊粉丙酸酯10-20千克为原料，经过将以上原料捡杂、清洗、沥干，加入1∶1-5的水浸泡8-12小时后，再加入8-10倍的水磨成浆液，送入过滤机，过滤后将黑藜麦浆液加热至60℃，在25MPa下进行均质后浓缩至含固体物40-50％，将浓缩后的黑藜麦浆液送入低温真空干燥机，真空度控制在0.696千帕，温度控制在30-40度，进行真空干燥，干燥时间2-4小时。干燥后的黑藜麦固体物进行粉碎后过80-100目筛(即黑藜麦速溶粉)，再与原料配方中剩余的原料胡椒碱、红藻萃取物、菊粉丙酸酯混合，充分搅拌均匀，经检验合格，包装为成品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711029459.4A CN107712875A (zh) | 2017-10-30 | 2017-10-30 | 黑藜麦减肥代餐 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711029459.4A CN107712875A (zh) | 2017-10-30 | 2017-10-30 | 黑藜麦减肥代餐 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107712875A true CN107712875A (zh) | 2018-02-23 |
Family
ID=61203088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711029459.4A Pending CN107712875A (zh) | 2017-10-30 | 2017-10-30 | 黑藜麦减肥代餐 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107712875A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108835264A (zh) * | 2018-06-07 | 2018-11-20 | 苟春虎 | 高级藜麦谷粒营养奶 |
| CN114990048A (zh) * | 2022-04-25 | 2022-09-02 | 福建省亚热带植物研究所 | 一种藜麦种子外泌体的制备方法及其用途 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104661680A (zh) * | 2012-07-31 | 2015-05-27 | 帝国创新有限公司 | 化合物及其对食欲控制和胰岛素敏感性的影响 |
| CN105815514A (zh) * | 2016-05-18 | 2016-08-03 | 苟春虎 | 藜麦减肥奶茶 |
| CN106306993A (zh) * | 2016-03-24 | 2017-01-11 | 田涛 | 藜麦营养代餐粉 |
| CN106616998A (zh) * | 2016-12-30 | 2017-05-10 | 北京康比特体育科技股份有限公司 | 一种营养代餐的组合物及其应用 |
| CN106819793A (zh) * | 2016-12-22 | 2017-06-13 | 安徽乔富食品配料销售有限公司 | 一种藜麦即食类营养代餐食品 |
| CN106957377A (zh) * | 2017-05-18 | 2017-07-18 | 沈阳科纳提克生物科技有限公司 | 一种菊粉丙酸酯的制备方法 |
| WO2017126959A1 (en) * | 2016-01-18 | 2017-07-27 | Innoso B.V. | Food composition with fermented starch |
| CN107212228A (zh) * | 2017-06-30 | 2017-09-29 | 成都南野食品有限公司 | 一种藜麦营养组合物、藜麦制品 |
-
2017
- 2017-10-30 CN CN201711029459.4A patent/CN107712875A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104661680A (zh) * | 2012-07-31 | 2015-05-27 | 帝国创新有限公司 | 化合物及其对食欲控制和胰岛素敏感性的影响 |
| WO2017126959A1 (en) * | 2016-01-18 | 2017-07-27 | Innoso B.V. | Food composition with fermented starch |
| CN106306993A (zh) * | 2016-03-24 | 2017-01-11 | 田涛 | 藜麦营养代餐粉 |
| CN105815514A (zh) * | 2016-05-18 | 2016-08-03 | 苟春虎 | 藜麦减肥奶茶 |
| CN106819793A (zh) * | 2016-12-22 | 2017-06-13 | 安徽乔富食品配料销售有限公司 | 一种藜麦即食类营养代餐食品 |
| CN106616998A (zh) * | 2016-12-30 | 2017-05-10 | 北京康比特体育科技股份有限公司 | 一种营养代餐的组合物及其应用 |
| CN106957377A (zh) * | 2017-05-18 | 2017-07-18 | 沈阳科纳提克生物科技有限公司 | 一种菊粉丙酸酯的制备方法 |
| CN107212228A (zh) * | 2017-06-30 | 2017-09-29 | 成都南野食品有限公司 | 一种藜麦营养组合物、藜麦制品 |
Non-Patent Citations (4)
| Title |
|---|
| 不详: "红藻提取物可抑制肥胖 ", 《中国食品学报》 * |
| 不详: "红藻提取物可抑制肥胖", 《中国食品学报》 * |
| 兰海云等: "肠道菌群对胰岛素敏感度的影响 ", 《医学研究杂志》 * |
| 杨潇等: "天然香辛料中抗肥胖成分的研究进展", 《西华大学学报(自然科学版)》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108835264A (zh) * | 2018-06-07 | 2018-11-20 | 苟春虎 | 高级藜麦谷粒营养奶 |
| CN114990048A (zh) * | 2022-04-25 | 2022-09-02 | 福建省亚热带植物研究所 | 一种藜麦种子外泌体的制备方法及其用途 |
| CN114990048B (zh) * | 2022-04-25 | 2023-11-21 | 福建省亚热带植物研究所 | 一种藜麦种子外泌体的制备方法及其用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108272073A (zh) | 一种减肥代餐粉及其制备方法 | |
| CN107692240A (zh) | 一种高蛋白膳食组合物及其制备方法和应用 | |
| CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
| CN110037287B (zh) | 一种桑椹酵素粉及其制备方法 | |
| JP2008174539A (ja) | 紫色の馬鈴薯を使用した肥満患者用の健康機能食品 | |
| CN105815514A (zh) | 藜麦减肥奶茶 | |
| CN101274078A (zh) | 一种天然植物提取物及其制备方法和应用 | |
| CN101147579B (zh) | 矿维五谷杂粮排毒抗衰养生保健食品 | |
| CN110692884A (zh) | 一种辅助降四高的益生菌保健饮料 | |
| CN108713755A (zh) | 藜麦瘦身营养奶昔 | |
| CN107712875A (zh) | 黑藜麦减肥代餐 | |
| CN111374312A (zh) | 一种补充全面营养且易吸收的健康食品 | |
| CN105707378A (zh) | 黑青稞瘦身咖啡 | |
| CN101755878A (zh) | 一种含有苦瓜山楂决明子的减肥蛋糕的制备方法 | |
| CN109303115A (zh) | 生酮减肥代餐奶昔 | |
| KR101350046B1 (ko) | 항비만 효능을 갖는 복합 생약 발효 식초 조성물 및 그 제조방법 | |
| CN113749152A (zh) | 一种健康养生强身饮品及其制备方法 | |
| CN107259318A (zh) | 一种营养保健食品 | |
| CN113841884A (zh) | 改善营养代谢的速溶代餐粉配方及其制作方法 | |
| JP2013177330A (ja) | イモ焼酎粕又はその処理物を含む抗炎症剤 | |
| CN106035686A (zh) | 超级藜麦养生植物奶 | |
| KR101344564B1 (ko) | 마라소스의 주성분인 고추 및 화초 추출물을 유효성분으로 함유하는 비만 또는 고지혈증 예방 및 치료용 조성물 | |
| KR20100037309A (ko) | 유산균을 이용한 환형 건강보조식품의 제조방법 | |
| CN111084317A (zh) | 一种保健型固体饮料及其制备方法 | |
| KR20050045666A (ko) | 비만억제 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180223 |